The PI3K pathway mediates cell motility, invasion, and metastasis, and NSCLC patients with activated PI3K/mTOR/AKT pathway (mutations in PIK3CA, PTEN, and STK11) in their primary tumors have shown shorter BM-free survival.25 Here, PIK3CA is linked to non-small cell lung carcinoma.